These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine]. Seubert S, Seubert A, Stella AM, Guzman H, Batlle A. Z Hautkr; 1990 Mar 15; 65(3):223-5. PubMed ID: 2339575 [Abstract] [Full Text] [Related]
14. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda. Moran MJ, Fontanellas A, Santos JL, Enriquez de Salamanca R. Int J Biochem Cell Biol; 1995 Jun 15; 27(6):585-8. PubMed ID: 7671136 [Abstract] [Full Text] [Related]
15. Photodynamic action of uroporphyrin on the complement system in porphyria cutanea tarda. Meurer M, Schulte C, Weiler A, Goerz G. Arch Dermatol Res; 1985 Jun 15; 277(4):293-8. PubMed ID: 3923948 [Abstract] [Full Text] [Related]
16. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy. Székely E, Vereckei A, Almási A, Rapavi E, Tasnádi G, Várnai K, Pallai Z, Lugasi A, Blázovics A. Clin Hemorheol Microcirc; 2007 Jun 15; 36(1):13-23. PubMed ID: 17211058 [Abstract] [Full Text] [Related]
17. [Treatment of porphyria cutanea tarda with and without phlebotomy (author's transl)]. Leonhardi G, Klähn KH, Gürenci J. MMW Munch Med Wochenschr; 1977 Jan 14; 119(2):43-6. PubMed ID: 401939 [Abstract] [Full Text] [Related]